Bajaj Finance Shares Surge 4% as MD Rajeev Jain Elevated to Vice Chairman Amid Top-Level Rejig
Bajaj Finance shares rose 4 percent on Friday after restructuring top management. Rajeev Jain was elevated to Vice Chairman and Anup Kumar Saha appointed as MD, boosting investor confidence.
Bajaj Finance Share Price: Bajaj Finance Ltd’s shares climbed 4 per cent during the intraday on Friday following the restructuring of top management in the company. India’s largest Non-Banking Financial Company (NBFC) on Thursday informed that the incumbent MD Rajeev Jain has been elevated as Vice Chairman for 3 years from April 1 and Deputy Managing Director Anup Kumar Saha has been appointed as MD of the Company.
Investors look at these elevations in the top managerial posts positively as shares move upward on Friday.
related stories
- IDFC First Bank Shares Rise Over 6% On Robust Q4 Update; Should You Invest?
- Shrimp Stocks Avanti Feeds, Apex Frozen Foods Crash Up To 17% After Trump Tariffs; Know Why
- Dabur Shares Tumble 7% To Hit 52-Week Low As FMCG Volume Trends Remain Subdued In Q4
- Nifty IT Falls 3% On Growth Concerns Post-Trump Tariff; Mphasis, Coforge Down 8%
The scrip was trading at Rs 8840 apiece with a gain of 1.85% on BSE around 10:23 AM. The stocks opened at Rs 8960, against the previous day close at Rs 8679.80 apiece. The stock’s 52-week movement indicates a high of Rs 9,070 and a low of Rs 6,376.55.
Bajaj Finance Ltd. has a market cap of Rs 5.47 lakh crore and is part of BSE Sensex.
Top-Level Rejig
Bajaj Finance Ltd has announced key leadership changes, elevating Managing Director Rajeev Jain to the position of Vice Chairman while appointing Deputy Managing Director Anup Kumar Saha as the new Managing Director.
In a regulatory filing, the company stated that the Board of Directors, based on the recommendation of the Nomination and Remuneration Committee, approved these changes at a meeting held on March 20, 2025.
Rajeev Jain, who has been instrumental in the company’s growth, will assume the role of Vice Chairman in an executive capacity for a three-year term starting April 1, 2025. His current tenure as MD is set to end on March 31, 2025. Meanwhile, Anup Kumar Saha, who currently serves as Deputy Managing Director, will take over as Managing Director from April 1, 2025. His tenure as DMD was originally set to run until March 31, 2028.
- Location :
- First Published: